US Senate Hearing explores use of Ivermectin as “Miracle Drug” for COVID-19 - Dec. 8, 2020

On December 8, 2020 the Senate Committee on Homeland Security and Governmental Affairs led by Senator Ron Johnson (R - WI) held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”. Appearing as witnesses were
Dr. Ramin Oskoui MD, Dr. Pierre Kory MD, Dr. Jean-Jacques Rajter MD, Dr. Armand Balboni MD PhD JD, Dr. Jane Orient MD, and Dr. Jayanta Bhattacharya.

Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin.

The data shows the ability of the drug Ivermectin to prevent COVID-19, to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and even to help critically ill patients recover.

Dr. Kory testified that Ivermectin is effectively a “miracle drug” against COVID-19 and called upon the government’s medical authorities—the NIH, CDC, and FDA—to urgently review the latest data and then issue guidelines for physicians, nurse-practitioners, and physician assistants to prescribe Ivermectin for COVID-19.